Pharmacokinetics of oral and intravenous ofloxacin in children with multidrug-resistant typhoid fever

Antimicrobial Agents and Chemotherapy

Volumn 40, Issue 9, 1996, Pages 2167-2172

  Bethell, Delia B ^a,b   Day, Nicholas P J ^a,b   Dung, Nguyen Minh ^a   Mcmullin, Caroline ^c   Loan, Ha Thi ^a   Tam, Dong Thi Hoai ^a   Minh, Le Thi Nguyet ^a   Linh, Nguyen Thi My ^a   Dung, Nguyen Quoc ^a   Vinh, Ha ^a   Macgowan, A P ^c   White, L O ^c   White, Nicholas J ^a,b,d  

^a Centre for Tropical Diseases Vietnam   (Viet Nam)

^b JOHN RADCLIFFE HOSPITAL   (United Kingdom)

^c NHS BLOOD AND TRANSPLANT   (United Kingdom)

^d CHO QUAN HOSPITAL   (Viet Nam)

Author keywords

[No Author keywords available]

Indexed keywords

OFLOXACIN;

ADOLESCENT; ARTICLE; CHILD; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DRUG BIOAVAILABILITY; DRUG BLOOD LEVEL; DRUG CLEARANCE; DRUG DISTRIBUTION; FEMALE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MALE; MEAN RESIDENCE TIME; MINIMUM INHIBITORY CONCENTRATION; MULTIDRUG RESISTANCE; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SALMONELLA TYPHI; TYPHOID FEVER; VIET NAM;

EID: 9544227478     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/aac.40.9.2167     Document Type: Article

References (27)

1. Acharya, G., C. Crevoisier, T. Butler, M. Ho, M. Tiwari, K. Stoeckel, and C. A. Bradley. 1994. Pharmacokinetics of ceftriaxone in patients with typhoid fever. Antimicrob. Agents Chemother. 38:2415-2418.
2. Bethell, D. B., T. T. Hien, L. T. Phi, N. P. J. Day, H. Vinh, N. M. Duong, N. V. Len, L. V. Chuong, and N. J. White. 1996. The effects on growth of single short courses of fluoroquinolones. Arch. Dis. Child. 74:44-46.
3. Burkhardt, J. E., M. A. Hill, W. W. Carlton, and J. W. Kesterson. 1990. Histologic and histochemical changes in articular cartilages of immature beagle dogs dosed with difloxacin fluoroquinolone. Vet. Pathol. 27:162-170.
4. Christ, W., T. Lehnert, and B. Ulbrich. 1988. Specific toxicologic aspects of the quinolones. Rev. Infect. Dis. 10:S141-S146.
5. Danisovicova, A., M. Brezina, S. Belan, H. Kaiserova, E. Kaiserova, I. Hruskovic, K. Orosova, S. Dluholucky, K. Galova, and E. Matheova. 1994. Magnetic resonance imaging in children receiving quinolones: no evidence of quinolone-induced arthropathy. A multicenter survey. Chemotherapy (Basel) 40:209-214.
6. Davies, B. I., F. P. V. Maesen, W. H. Geraedts, and C. Baur. 1987. Penetration of ofloxacin from blood to sputum. Drugs 34:26-32.
7. Drusano, G. L., D. E. Johnson, M. Rosen, and H. C. Standiford. 1993. Pharmacodynamics of a fluoroquinolone antimicrobial agent in a neutropenic rat model of Pseudomonas sepsis. Antimicrob. Agents Chemother. 37:483-490.
8. Dunne, A. 1985. A new iterative polyexponential curve stripping program. Comput. Methods Programs Biomed. 20:269-275.
9. Elin, R. J., E. S. Vesell, and M. S. Wolff. 1975. Effects of etiocholanolone-induced fever on plasma antipyrine half-lives and metabolic clearance. Clin. Pharmacol. Ther. 17:447.
10. el-Sherbini, A. 1991. An outbreak of typhoid fever resistant to chloramphenicol and other drugs in Gharbīya Governorate in Egypt. J. Trop. Pediatr. 38:331-334.
11. Farinotti, R., J. H. Trouvin, V. Bocquet, N. Vermerie, and C. Carbon. 1988. Pharmacokinetics of ofloxacin after single and multiple intravenous infusions in healthy subjects. Antimicrob. Agents Chemother. 32:1590-1592.
12. Flor, S. 1989. Pharmacokinetics of ofloxacin: an overview. Am. J. Med. 87:S24.
13. Forrest, A., D. E. Nix, C. H. Ballow, T. F. Goss, M. C. Birmingham, and J. J. Schentag. 1993. Pharmacodynamics of intravenous ciprofloxacin in seriously ill patients. Antimicrob. Agents Chemother. 37:1073-1081.
14. Forsyth, J. S., T. A. Moreland, and G. W. Rylance. 1982. The effect of fever on antipyrine metabolism in children. Br. J. Clin. Pharmacol. 13:811.
15. Gibaldi, M. 1984. Biopharmaceutics and clinical pharmacokinetics, 3rd ed. Lea & Febiger, Philadelphia.
16. Gough, A., N. J. Barsoum, L. Mitchell, E. J. McGuire, F. A. de la Iglesia. 1979. Juvenile canine drug-induced arthropathy: clinicopathological studies on articular lesions caused by oxolinic and pipemidic acids. Toxicol. Appl. Pharmacol. 51:177-187.
17. Hien, T. T., D. B. Bethell, N. T. T. Hoa, J. Wain, T. S. Diep, L. T. Phi, B. M. Cuong, N. M. Duong, P. T. Thanh, A. L. Walsh, N. P. J. Day, and N. J. White. 1995. Short course ofloxacin treatment of multi-drug resistant typhoid. Clin. Infect. Dis. 20:917-923.
18. Monk, J. P., and D. M. Campoli-Richards. 1987. Ofloxacin: a review of ils antibacterial activity, pharmacokinetic properties and therapeutic use. Drugs 33:346-391.
19. Schaad, U. B., A. S. Mohammed, A. Yannick, R. Dagan, S. D. R. Green, H. Peltola, T. T. Rubio, A. L. Smith, and A. Dieter. 1995. Use of fluoroquinolones in pediatrics: consensus report of an International Society of Chemotherapy commission. Pediatr. Infect. Dis. J. 14:1-9.
20. Schaad, U. B., C. Stoupis, J. Wedgwood, H. Tschaeppeler, and P. Vock. 1991. Clinical, radiologic and magnetic resonance monitoring for skeletal toxicity in pediatric patients with cystic fibrosis receiving a three-month course of ciprofloxacin. Pediatr. Infect. Dis. J. 10:723-729.
21. Schaad, U. B., and J. Wedgwood-Krucko. 1987. Nalidixic acid in children: retrospective matched controlled study for cartilage toxicity. Infection 15: 165-168.
22. Shah, P. M., C. Malercyzk, V. Schafer, V. Brade, and W. Still. 1995. The pharmacokinetics of once-daily ofloxacin, 400 mg po and IV, and its influence on pharyngeal and bowel flora. Poster presentation at the 19th International Congress of Chemotherapy, Montreal.
23. Sitprija, V., V. Pipatanagul, and V. Boonpuknavig. 1974. Glomerulitis in typhoid fever. Ann. Intern. Med. 81:210.
24. Smith, M. D., N. M. Duong, N. T. T. Hoa, J. Wain, H. D. Ha, T. S. Diep, N. P. J. Day, T. T. Hien, and N. J. White. 1994. Comparison of ofloxacin and ceftriaxone for short-course treatment of enteric fever. Antimicrob. Agents Chemother. 38:1716-1720.
25. 24a. Vinh, H., J. Wain, V. T. N. Hanh, C. N. Nga, M. T. Chinh, D. Bethell, N. T. T. Hoa, T. S. Diep, N. M. Dung, and N. J. White. 1996. Two or three days of ofloxacin for uncomplicated multidrug-resistant typhoid fever in children. Antimicrob. Agents Chemother. 40:958-961.
26. White, L. O., H. Bowyer, C. McMullin, and A. M. Lovering. 1989. The therapeutic monitoring of 4-quinolone antibacterials with special reference to ciprofloxacin, p. 351-367. In P. B. Fernandes and J. R. Prous (ed.), International telesymposium on quinolones. Barcelona, Spain.
27. Yamaoka, K., T. Nakagawa, and T. Uno. 1978. Application of Akaike's information criterion (AIC) in the evaluation of linear pharmacokinetic equations. J. Pharmacokinet. Biopharm. 6:165-175.